Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 1501 AL 1515

Efficacy and safety of intravesical onabotulinumtoxinA injection on elderly patients with chronic central nervous system lesions and overactive bladder

Jiang YH, Liao CH, Tang DL, Kuo HC.

PLoS One. 2014 Aug 22;9(8):e105989. doi: 10.1371/journal.pone.0105989. eCollection 2014.

Mitochondrial acetylation and genetic models of Parkinson's disease

Auburger G, Gispert S, Jendrach M.

Prog Mol Biol Transl Sci. 2014;127:155-82. doi: 10.1016/B978-0-12-394625-6.00006-4.

Correlation between the biochemical pathways altered by mutated parkinson-related genes and chronic exposure to manganese

Roth JA.

Neurotoxicology. 2014 Sep;44:314-25. doi: 10.1016/j.neuro.2014.08.006. Epub 2014 Aug 19.

Directional steering: A novel approach to deep brain stimulation

Contarino MF, Bour LJ, Verhagen R, Lourens MA, de Bie RM, van den Munckhof P, Schuurman PR.

Neurology. 2014 Sep 23;83(13):1163-9. doi: 10.1212/WNL.0000000000000823. Epub 2014 Aug 22.

Stimulation of the subthalamic area modulating movement and behavior

Ricciardi L, Morgante L, Epifanio A, Zibetti M, Lanotte M, Lopiano L, Morgante F.

Parkinsonism Relat Disord. 2014 Nov;20(11):1298-300. doi: 10.1016/j.parkreldis.2014.07.013. Epub 2014 Aug 9.

Parkinson's disease and mitochondrial gene variations: a review

Andalib S, Vafaee MS, Gjedde A.

J Neurol Sci. 2014 Nov 15;346(1-2):11-9. doi: 10.1016/j.jns.2014.07.067. Epub 2014 Aug 7.

Dysregulation of protein trafficking in neurodegeneration

Wang X, Huang T, Bu G, Xu H.

Mol Neurodegener. 2014 Aug 25;9:31. doi: 10.1186/1750-1326-9-31.

Targeting the NMDA receptor subunit NR2B for treating or preventing age-related memory decline

Wang D, Jacobs SA, Tsien JZ.

Expert Opin Ther Targets. 2014 Oct;18(10):1121-30. doi: 10.1517/14728222.2014.941286. Epub 2014 Aug 24.

Diffusion tensor imaging differentiates vascular parkinsonism from parkinsonian syndromes of degenerative origin in elderly subjects

Deverdun J, Menjot de Champfleur S, Cabello-Aguilar S, Maury F, Molino F, Charif M, Leboucq N, Ayrignac X, Labauge P, Bonafe A, Castelnovo G, Le Bars E, Geny C, Menjot de Champfleur N.

Eur J Radiol. 2014 Nov;83(11):2074-9. doi: 10.1016/j.ejrad.2014.07.012. Epub 2014 Jul 24.

Visual hallucinations in Parkinson's disease: theoretical models

Muller AJ, Shine JM, Halliday GM, Lewis SJ.

Mov Disord. 2014 Nov;29(13):1591-8. doi: 10.1002/mds.26004. Epub 2014 Aug 22.

From micrographia to Parkinson's disease dysgraphia

Letanneux A, Danna J, Velay JL, Viallet F, Pinto S.

Mov Disord. 2014 Oct;29(12):1467-75. doi: 10.1002/mds.25990. Epub 2014 Aug 22.

Mixed effects of deep brain stimulation on depressive symptomatology in Parkinson's disease: a review of randomized clinical trials

Gökbayrak NS, Piryatinsky I, Gavett RA, Ahmed OJ.

Front Neurol. 2014 Aug 11;5:154. doi: 10.3389/fneur.2014.00154. eCollection 2014.

[A case report of Parkinson's disease presenting with olfactory disturbance as a primary symptom in the early stage]

Fujio H, Inokuchi G, Fukuda Y, Hasegawa S, Ootsuki N, Nibu K.

Nihon Jibiinkoka Gakkai Kaiho. 2014 Jul;117(7):932-5. doi: 10.3950/jibiinkoka.117.932.

Gene therapy for the nervous system: challenges and new strategies

Maguire CA, Ramirez SH, Merkel SF, Sena-Esteves M, Breakefield XO.

Neurotherapeutics. 2014 Oct;11(4):817-39. doi: 10.1007/s13311-014-0299-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias